Human B7-2, Fc Tag on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized Human B7-2, Fc Tag at 5 ug/mL (100 uL/well) can bind Biotinylated Human CTLA-4, Fc Tag, Avi Tag with a linear range of 0.6-10 ng/mL.
Immobilized Biotinylated Mouse CD28, His,Avitag at 1 ug/mL (100 uL/well) on Streptavidin precoated (0.5 ug/well) plate, can bind Human B7-2, Fc Tag with a linear range of 5-78 ng/mL.
Immobilized Biotinylated Human / Cynomolgus / Rhesus macaque CD28, His,Avitag at 1 ug/mL (100 uL/well) on Streptavidin precoated (0.5 ug/well) plate, can bind Human B7-2, Fc Tag with a linear range of 2-78 ng/mL.
Loaded Human B7-2, Fc Tag on Protein A Biosensor, can bind Human / Cynomolgus / Rhesus macaque CD28, His Tag with an affinity constant of 4.5 uM as determined in BLI assay (ForteBio Octet Red96e).
Loaded Human B7-2, Fc Tag on Protein A Biosensor, can bind Human CTLA-4, His Tag, active dimer with an affinity constant of 1.03 nM as determined in BLI assay (ForteBio Octet Red96e).
Flow Cytometry assay shows that recombinant Human B7-2, Fc Tag can bind to CD28 expressed on Jurkat E6.1. The concentration of B7-2 used is 2 ug/ml.
FACS analysis shows that the binding of Human B7-2, Fc Tag to CD28 expressed on Jurkat E6.1 was inhibited by increasing concentration of neutralizing anti-CD28 antibody. The concentration of B7-2 used is 2 ug/ml. The IC50 is 0.022 ug/ml.
FACS assay shows that Human B7-2, Fc Tag can bind to 293T cells overexpressing human CTLA4 protein. The concentration of Human B7-2 is 3 ug/ml.